Royal London Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Sell |
|
|||||
|
2025
Q1 | $6.02M | Buy |
|
|||||
|
2024
Q4 | $5.05M | Sell |
|
|||||
|
2024
Q3 | $5.44M | Buy |
|
|||||
|
2024
Q2 | $6.03M | Buy |
|
|||||
|
2024
Q1 | $6.31M | Sell |
|
|||||
|
2023
Q4 | $7.12M | Buy |
|
|||||
|
2023
Q3 | $6.36M | Buy |
|
|||||
|
2023
Q2 | $5.92M | Buy |
|
|||||
|
2023
Q1 | $6.11M | Sell |
|
|||||
|
2022
Q4 | $6.61M | Hold |
|
|||||
|
2022
Q3 | $5.42M | Sell |
|
|||||
|
2022
Q2 | $5.32M | Sell |
|
|||||
|
2022
Q1 | $4.96M | Buy |
|
|||||
|
2021
Q4 | $5.37M | Sell |
|
|||||
|
2021
Q3 | $4.86M | Sell |
|
|||||
|
2021
Q2 | $5.42M | Hold |
|
|||||
|
2021
Q1 | $4.9M | Hold |
|
|||||
|
2020
Q4 | $5.69M | Sell |
|
|||||
|
2020
Q3 | $4.96M | Sell |
|
|||||
|
2020
Q2 | $7.98M | Sell |
|
|||||
|
2020
Q1 | $5.73M | Hold |
|
|||||
|
2019
Q4 | $5.88M | Hold |
|
|||||
|
2019
Q3 | $4.69M | Sell |
|
|||||
|
2019
Q2 | $6.02M | Hold |
|
|||||
|
2019
Q1 | $6.24M | Sell |
|
|||||
|
2018
Q4 | $6.41M | Buy |
|
|||||
|
2018
Q3 | $6.97M | Sell |
|
|||||
|
2018
Q2 | $6.8M | Buy |
|
|||||
|
2016
Q2 | $4.32M | Sell |
|
|||||
|
2016
Q1 | $38K | Buy |
|
|||||
|
2015
Q4 | $5.89M | Sell |
|
|||||
|
2015
Q3 | $5.95M | Buy |
|
|||||
|
2014
Q4 | $42K | Buy |
|
|||||
|
2014
Q3 | $2.51M | Buy |
|
|||||
|
2014
Q2 | $2.11M | Sell |
|
|||||
|
2014
Q1 | $1.93M | Buy |
|